Re-assessment of the primary efficacy outcomes of cefepime/enmetazobactam vs piperacillin/tazobactam in adult patients with complicated urinary tract infections or acute pyelonephritis using updated EUCAST piperacillin/tazobactam susceptibility breakpoints

piperacillin sodium/tazobactam sodium - Generic mfg.

Exblifep (cefepime/enmetazobactam) - Allecra

J.L. Quevedo Marin*; A. Belley; N. Dunkel; P. Velicitat

Feb 1, 2024